Trial intelligence / Profile preview

Risperidone effects on cognitive rigidity in children with autism spectrum disorder

NL-OMON34499Active, not recruiting

Sponsor
University Medical Center Utrecht
Start
Feb 2011
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of risperidone in Autism Spectrum Disorder (ASD), sponsored by University Medical Center Utrecht. Primary endpoints: Error-related negativity amplitude, Post-error slowing and 1 more. Started Feb 2011; status: active, not recruiting.

02

Drugs

risperidone
03

Conditions

Autism Spectrum Disorder (ASD)

Beyond the preview

Go deeper on NL-OMON34499.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON34499.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call